COVID-19 Collection

Journal article : Correspondence

Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Tibble, H., Mueller, T., Proud, E., Hall, E., Kurdi, A., Robertson, C., Bennie, M., Woolford, L., & Sheikh, A. (2022). Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland. Lancet, 401(10371), 101–102.

MLA Style

Tibble, H, et al. “Uptake of Monoclonal Antibodies and Antiviral Therapies for COVID-19 in Scotland.” Lancet, vol. 401, no. 10371, 2022, pp. 101–02.

Chicago Style

Tibble, H, T Mueller, E Proud, et al. 2022. “Uptake of Monoclonal Antibodies and Antiviral Therapies for COVID-19 in Scotland.” Lancet 401 (10371): 101–2.
Print

Access Document

Publisher copy:: 10.1016/s0140-6736(22)02398-4

Authors

+ Tibble, H More by this author

Role:: Author

+ Mueller, T More by this author

Role:: Author

+ Proud, E More by this author

Role:: Author

+ Hall, E More by this author

Role:: Author

+ Kurdi, A More by this author

Role:: Author

More authors...

+ UK Research and Innovation More from this funder

Funder identifier:: https://ror.org/001aqnf71

Publisher:: Elsevier
Journal:: Lancet More from this journal
Volume:: 401
Issue:: 10371
Pages:: 101-102
Place of publication:: England
Publication date:: 2022-12-22
Acceptance date:: 2022-11-14
DOI:: 10.1016/s0140-6736(22)02398-4
EISSN:: 1474-547X
ISSN:: 0140-6736
Pmid:: 36566764

Language:: English
Subtype:: Correspondence
Pubs id:: 2039954
Local pid:: pubs:2039954
Source identifiers:: W4312193649
Deposit date:: 2026-05-08
ARK identifier:: ark:/29072/ora_c6d5e41e9b024ef7a3b780324c0be1ed

Terms of use

Copyright holder:: Elsevier Ltd.
Copyright date:: 2022
Rights statement:: © 2022 Elsevier Ltd. All rights reserved.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP